×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SMS PHARMACEUTICALS LTD. | 1,754.81 | 182.42 | 1,733.53 | 2.15 | 1,816 | 27.5 |
| AMRUTANJAN HEALTH CARE LTD. | 1,271.12 | 192.46 | 1,227.52 | 6.66 | 1730 | 84.9 |
| Windlas Biotech Limited | 1991.26 | 155.76 | 1950.19 | 7.38 | 1652 | 26.8 |
SMS Pharmaceuticals Ltd, with Security Code 532815, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 64.3 | 159.4 | 148.8 | 149.4 | 135.3 | 166.6 | 161.4 | 245.7 | 164.4 | 196.7 |
| Expenses | 64.8 | 145.8 | 130.5 | 126.2 | 108.7 | 138.8 | 132.6 | 212.3 | 131.0 | 164.9 |
| Operating Profit | -0.4 | 13.6 | 18.3 | 23.2 | 26.7 | 27.8 | 28.9 | 33.5 | 33.5 | 31.9 |
| OPM % | -0.66% | 8.54% | 12.27% | 15.56% | 19.7% | 16.7% | 17.88% | 13.62% | 20.35% | 16.19% |
| Other Income | 0.8 | 0.6 | 2.2 | 1.3 | 0.5 | 0.8 | 1.5 | 1.6 | 1.4 | 1.3 |
| Interest | 4.9 | 5.2 | 5.9 | 5.9 | 6.3 | 5.6 | 6.0 | 5.6 | 4.7 | 4.6 |
| Depreciation | 7.9 | 8.1 | 8.1 | 8.0 | 7.7 | 7.9 | 8.0 | 7.9 | 8.4 | 8.6 |
| Profit before tax | -12.4 | 0.9 | 6.4 | 10.6 | 13.2 | 15.2 | 16.4 | 21.6 | 21.8 | 19.9 |
| Tax % | -21% | 12.1% | 21.7% | 24.1% | 29.4% | 20.5% | 25.8% | 26.3% | 25% | 28.5% |
| Net Profit | -9.8 | 0.8 | 5.0 | 8.1 | 9.3 | 12.0 | 12.2 | 15.9 | 16.3 | 14.3 |
| EPS in Rs | -1.16 | 0.09 | 0.59 | 0.95 | 1.1 | 1.42 | 1.44 | 1.88 | 1.93 | 1.68 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 159.4 | 148.8 | 149.4 | 135.3 | 166.6 | 161.5 | 245.8 | 164.5 | 196.7 | 173.4 |
| Expenses | 148.6 | 131.8 | 128.0 | 109.2 | 139.1 | 133.3 | 212.2 | 130.9 | 165.3 | 140.1 |
| Operating Profit | 10.8 | 17.0 | 21.4 | 26.2 | 27.5 | 28.2 | 33.6 | 33.5 | 31.5 | 33.2 |
| OPM % | 6.8% | 11.4% | 14.3% | 19.3% | 16.5% | 17.5% | 13.7% | 20.4% | 16% | 19.2% |
| Other Income | 0.6 | 2.2 | 1.3 | 0.5 | 0.8 | 1.5 | 1.6 | 1.4 | 1.3 | 2.1 |
| Interest | 5.2 | 5.9 | 5.9 | 6.3 | 5.6 | 6.0 | 5.6 | 4.7 | 4.6 | 4.2 |
| Depreciation | 8.1 | 8.1 | 8.0 | 7.7 | 7.9 | 8.0 | 7.9 | 8.4 | 8.6 | 8.7 |
| Profit before tax | -1.9 | 5.2 | 8.8 | 12.7 | 14.8 | 15.7 | 21.7 | 21.8 | 19.5 | 22.4 |
| Tax % | 12.9% | 20.9% | 24.1% | 30.5% | 20.5% | 25.6% | 26.2% | 25% | 29.1% | 23.9% |
| Net Profit | -2.0 | 3.8 | 6.2 | 9.3 | 11.7 | 11.5 | 17.3 | 16.5 | 14.1 | 18.2 |
| EPS in Rs | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 53% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 41% |
| 3 Years: | 28% |
| 1 Year: | 51% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 41% |
| 3 Years: | 28% |
| 1 Year: | 51% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|